University of New South Wales

The University of New South Wales provides advanced biomedical research, nanotechnology development, and public health analysis. Their core capabilities include the engineering of self-powered nanorobots for targeted oncology therapies, the development of nanotechnology-based blood tests for early cancer detection, and the creation of custom 3D models to study cancer heterogeneity. The institution specializes in genomic medicine, focusing on genetic mutations related to birth defects and the study of genetic variation in under-represented populations. Additionally, they possess expertise in point-of-care diagnostic testing for infectious diseases, critical care survivorship research, and the application of legal frameworks to improve public nutrition. The institution works most frequently with the National Health and Medical Research Council, delivering a wide array of high-impact medical research projects ranging from molecular biology and oncology to public health policy. They also maintain a working relationship with the Department of Defence.